Presented by The Conference Forum in collaboration with the Society for Immunotherapy of Cancer
With promising cancer immunotherapies in the clinic and an encouraging pipeline of new targets being developed, additional discoveries are now under way to determine the most effective rational combinations for individual patients and for specific tumor types. Increased emphasis on prioritizing combinations will be crucial for decision-making. As a result, novel therapies and innovative trial designs are creating increased momentum for investment/business development opportunities. Rational Combinations 360° will provide up-to-date progress on combination developments in terms of business aspects, clinical advancements and scientific data to prioritize cancer treatments for individual patients and tumor types. SITC President, Lisa Butterfield, PhD (University of Pittsburgh) will be speaking at this program.
The Rational Combinations 360° event will delve into key areas including:
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org